Guidelines & Advice

Treatment

Treatment is determined by the type and stage of cancer, as well as by what treatments and services a patient chooses. The guidelines and other documents available here focus on topics related to the treatment of cancer in Ontario.

Multidisciplinary Cancer Conferences

Displaying Guidelines

45 Items

Systemic Therapy for Metastatic Urothelial Cancer: An Endorsement of a Portion of the European Association of Urology Guideline on Muscle-Invasive and Metastatic Bladder Cancer

Document Status: In-Review
ID: GL END 3-24

Aug 2022

Systemic therapy for the treatment of adult patients with lower-risk myelodysplastic syndromes

Document Status: In-Review
ID: 6-13

Mar 2018

Systemic Therapy in Men with Metastatic Castration-Resistant Prostate Cancer: American Society of Clinical Oncology and Cancer Care Ontario Clinical Practice Guideline

Document Status: In-Review
ID: 3-15
Version: 2

Sep 2014

Systemic Treatment of Acute Myeloid Leukemia (AML)

Document Status: In-Review
ID: 12-9

Jan 2016

The Management of Depression in Patients with Cancer

Document Status: In-Review
ID: 19-4

May 2015

The Use of Systemic Treatment in the Maintenance of Patients with Non-Small Cell Lung Cancer

Document Status: In-Review
ID: 7-22

Aug 2015

The Use of Targeted Therapies in Patients with Inoperable Locally Advanced or Metastatic Renal Cell Cancer: Updated Guideline 2017

Document Status: In-Review
ID: 3-8-4
Version: 2

May 2017

Treatment of Multiple Myeloma: ASCO and CCO Joint Clinical Practice Guideline

Document Status: In-Review
ID: GL 6-A-2018-1

Mar 2019

Use of the Epidermal Growth Factor Receptor Inhibitors Gefitinib (Iressa®), Erlotinib (Tarceva®), Afatinib, Dacomitinib or Icotinib in the Treatment of Non–SmallCell Lung Cancer: A Clinical Practice Guideline

Document Status: In-Review
ID: 7-9
Version: 2

Apr 2014